Tag:

Perrigo

Latest Headlines

Latest Headlines

Perrigo nails down dermatology spot with $45M deal

Perrigo has further solidified its position in topical dermatology drugs, one of the areas in which prices have been escalating of late.

GOP or Dem? Some pharma donors don't hedge their bets

It's the endgame for 2012 election candidates--and for supporters that have shelled out cash to support their bids for votes. As usual, the pharma business is right there in the fray, with political action committees and employees donating hundreds of thousands, if not millions.

Bayer picks up Teva's animal health biz for $145M

In the second animal health deal announced in two days, generic drug giant Teva Pharmaceutical Industries says it will sell its animal products line to Bayer of Germany for $145 million so it can concentrate on human drugs.

Fast-growing generics maker Perrigo moves into pet care

The Michigan-based company, best known for its generics and OTC drugs, purchased Sergeant's Pet Care Products for $285 million. 

Generic cream price spikes have experts scratching their heads

While the pharma industry has been criticized over the high cost of cancer drugs and alleged price manipulation of wholesale prices, it is the cost of generic ointments that is setting some consumers off and leaving some experts scratching their heads.

Pharma CFOs grab spotlight in WSJ ranking

It's tricky to pick the best of anything. But The Wall Street Journal gives it a try with a new ranking of the best CFOs, focusing on the executives who not only keep their own numbers in order, but also help craft company strategy. And pharma has reason to boast about this list: Of the 25 CFOs chosen, three hail from drugmakers.

Zacks rewards Perrigo's speedy QA turnaround

Zacks likes Perrigo, and why not? Active pharmaceutical ingredient sales are up 26 percent over a year ago, to $41 million. But even more impressive is how the recently quality-challenged generics

J&J, generics makers to revamp children's Tylenol products

Tylenol maker Johnson & Johnson will revamp its product line for infants and children to help prevent overdoses of the pain and fever remedy. The company plans to make all children's Tylenol

FDA's OK of Perrigo plant signals SOP fixes

The FDA's all-clear sign for Perrigo's Michigan manufacturing plant this week is in some ways an understatement of what must have happened there. Inspectors arrived on March 1 and Perrigo announced

Perrigo gets FDA clearance at troubled plant

A year after receiving a warning from regulators, generics maker Perrigo said its manufacturing facility in Allegan, MI, has won FDA's approval. Report